journal article·2014-04-09

Aerosol-Based Fabrication of Modified Chitosans and Their Application for Gene Transfection

Jeong Hoon Byeon, Hee-Kwon Kim, David H. Thompson, Jeffrey T. Roberts

Publisher page

Abstract

Modified chitosan nanoparticles were conveniently obtained by a one-step aerosol method, and their potential for gene transfection was investigated. Droplets containing modified chitosans were formed by collison atomization, dried to form solid particles, and collected and studied for potential use as nanocarriers. Modified chitosans consisted of a chitosan backbone and an additional component [covalently attached cholesterol; or blends with poly(l-lysine) (PLL), polyethyleneimine (PEI), or poly(ethylene glycol) (PEG)]. Agarose gel retardation assays confirmed that modified chitosans could associate with plasmid DNA. Even though the average cell viability of cholesterol-chitosan (Ch-Cs) showed a slightly higher cytotoxicity (∼90% viability) than that for unmodified chitosan (Cs, ∼95%), transfection (>7.5 × 10(5) in relative light units (RLU) mg(-1)) was more effective than it was for Cs (∼7.6 × 10(4) RLU mg(-1)). The blending of PEI with Cs (i.e., a Cs/PEI) to produce transfection complexes enhanced the transfection efficiency (∼1.3 × 10(6) RLU mg(-1)) more than did the addition of PLL (i.e., a Cs/PLL, ∼9.3 × 10(5) RLU mg(-1)); however, it also resulted in higher cytotoxicity (∼86% viability for Cs/PEI vs ∼94% for Cs/PLL). The average cell viability (∼92%) and transfection efficiency (∼1.9 × 10(6) RLU mg(-1)) were complemented further by addition of PEG in Cs/PEI complexes (i.e., a Cs/PEI-PEG). This work concludes that gene transfection of Cs can be significantly enhanced by adding cationic polymers during aerosol fabrication without wet chemical modification processes of Cs.
Source: openalex_inverted_index · Quality: baseline

Research context

OpenAlex topics: RNA Interference and Gene Delivery · Advanced biosensing and bioanalysis techniques · SARS-CoV-2 detection and testing

SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.

Affiliations

Department of Chemistry, Purdue University, West Lafayette, Indiana 47907, United States

Department of Nuclear Medicine, Molecular Imaging & Therapeutic Medicine Research Center, Biomedical Research Institute, Chonbuk National University Medical School and Hospital, Jeonju 561-712, Republic of Korea

References (36)

Show source-provided references
1. Nel A. E. · Nat. Mater. · 2009 · 8 · 54310.1038/nmat2442 ↗
2. Karmi A. · J. Nanosci. Nanotechnol. · 2011 · 11 · 467510.1166/jnn.2011.4156 ↗
3. De M. · Adv. Mater. · 2008 · 20 · 422510.1002/adma.200703183 ↗
4. Murphy C. J. · Acc. Chem. Res. · 2008 · 41 · 172110.1021/ar800035u ↗
5. Sun X. · Mini-Rev. Med. Chem. · 2010 · 10 · 10810.2174/138955710791185109 ↗
6. Verma A. · Small · 2010 · 6 · 1210.1002/smll.200901158 ↗
7. Lai W.-F. · J. Controlled Release · 2009 · 134 · 15810.1016/j.jconrel.2008.11.021 ↗
8. Wu Y. · J. Polym. Res. · 2008 · 15 · 18110.1007/s10965-007-9157-z ↗
9. Duceppe N. · Expert Opin. Drug Delivery · 2010 · 7 · 119110.1517/17425247.2010.514604 ↗
10. Madihally S. V. · Biomaterials · 1999 · 20 · 113310.1016/S0142-9612(99)00011-3 ↗
11. Liang X. F. · Langmuir · 2008 · 24 · 714710.1021/la703775a ↗
12. Nandanan E. · Adv. Mater. · 2008 · 20 · 206810.1002/adma.200702193 ↗
13. Saranya N. · Int. J. Biol. Macromol. · 2011 · 48 · 23410.1016/j.ijbiomac.2010.11.013 ↗
14. Kim T.-H. · Prog. Polym. Sci. · 2007 · 32 · 72610.1016/j.progpolymsci.2007.05.001 ↗
15. Liu Z. · Drug Delivery · 2009 · 16 · 34110.1080/10717540903047387 ↗
16. Yang S. J. · Bioconjugate Chem. · 2010 · 21 · 67910.1021/bc9004798 ↗
17. Lee C. M. · Pharm. Res. · 2010 · 27 · 71210.1007/s11095-010-0072-3 ↗
18. Kievit F. M. · Adv. Funct. Mater. · 2009 · 19 · 224410.1002/adfm.200801844 ↗
19. Yu H. · Macromol. Biosci. · 2011 · 11 · 35210.1002/mabi.201000283 ↗
20. Craig D. Q. M. · Int. J. Pharm. · 2002 · 231 · 13110.1016/S0378-5173(01)00891-2 ↗
21. Bulmus V. · Macromol. Biosci. · 2007 · 7 · 44610.1002/mabi.200600258 ↗
22. Flores-Fernández G. M. · J. Pharm. Pharmacol. · 2009 · 61 · 155510.1211/jpp.61.11.0016 ↗
23. Thompson C. J. · J. Microencapsulation · 2009 · 26 · 67610.3109/02652040802656333 ↗
24. Boissiere C. · Adv. Mater. · 2011 · 23 · 59910.1002/adma.201001410 ↗
25. Edwards D. A. · Annu. Rev. Biomed. Eng. · 2002 · 4 · 9310.1146/annurev.bioeng.4.100101.132311 ↗
26. Ré M.-I. · Drying Technol. · 2006 · 24 · 43310.1080/07373930600611877 ↗
27. Rizi K. · J. Pharm. Sci. · 2011 · 100 · 56610.1002/jps.22291 ↗
28. Dolovich M. B. · Lancet · 2011 · 377 · 103210.1016/S0140-6736(10)60926-9 ↗
29. Packhaeuser C. B. · Pharm. Res. · 2009 · 26 · 12910.1007/s11095-008-9714-0 ↗
30. Hadinoto K. · Int. J. Pharm. · 2007 · 333 · 18710.1016/j.ijpharm.2006.10.009 ↗
31. Byeon J. H. · Macromol. Rapid Commun. · 2012 · 33 · 184010.1002/marc.201200369 ↗
32. Xu Z. · Carbohydr. Polym. · 2009 · 78 · 4610.1016/j.carbpol.2009.04.019 ↗
33. Ma K. · Biomaterials · 2009 · 30 · 610910.1016/j.biomaterials.2009.07.036 ↗
34. Liang G. F. · Nanoscale Res. Lett. · 2011 · 6 · 44710.1186/1556-276X-6-447 ↗
35. Blum J. S. · J. Controlled Release · 2008 · 129 · 6610.1016/j.jconrel.2008.04.002 ↗
36. Li Z.-T. · Carbohydr. Polym. · 2010 · 80 · 25410.1016/j.carbpol.2009.11.021 ↗